Why is antimicrobial stewardship important in the NICU and what strategies support it?

• A. To prevent resistance and toxicity; use narrow-spectrum therapy when possible, de-escalate based on cultures, follow local guidelines, and monitor antibiotic exposure.
• B. To maximize antibiotic use; prescribe broad-spectrum therapy for all suspected infections.
• C. Not necessary in the NICU; treat with broad-spectrum for all exposures.
• D. Always use fixed durations regardless of cultures.

Answer: (A)

Antimicrobial stewardship in the NICU is about using the right antibiotic in the right way to protect the tiniest patients and preserve antibiotics for the future. In neonates, immature organ systems and evolving weight-based dosing mean drugs can behave differently, so starting with a narrow-spectrum agent whenever possible helps limit unnecessary exposure. When culture results or clinical response provide more information, de-escalating to a narrower drug or stopping therapy reduces the risk of selecting resistant organisms and lowers the chance of drug toxicity. Following local guidelines ensures treatment aligns with the pathogens and resistance patterns actually seen in that unit, and close monitoring of antibiotic exposure—considering duration, dosing, and route changes—helps prevent adverse effects and overuse that can disrupt the developing microbiome.

Choosing to maximize antibiotic use, treating all suspected infections with broad-spectrum therapy, or sticking to fixed durations regardless of culture results ignores the variability of infection and promotes resistance and toxicity. Stewardship aims for targeted, culture-guided therapy and appropriate durations to protect both the infant and the broader patient population.